Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo

Journal of Gene Medicine

Volumn 3, Issue 4, 2001, Pages 362-372

  Wightman, Lionel ^a   Kircheis, Ralf ^a   Rössler, Vanessa ^a   Garotta, Sebastian ^b   Ruzicka, Regina ^a   Kursa, Malgorzata ^a   Wagner, Ernst ^a,b,c  

^a BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Gene therapy; Gene transfer; Non viral vectors; Polyethylenimine

Indexed keywords

DNA; DRUG CARRIER; GREEN FLUORESCENT PROTEIN; LUCIFERASE; PHOTOPROTEIN; POLYETHYLENEIMINE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CELL DIVISION; EXPERIMENTAL MELANOMA; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METHODOLOGY; MOUSE; REPORTER GENE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL DIVISION; DNA; DRUG CARRIERS; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUCIFERASES; LUMINESCENT PROTEINS; MELANOMA, EXPERIMENTAL; MICE; POLYETHYLENEIMINE; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0035408714     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.187     Document Type: Article

References (29)

1. Lollo CP, Banaszczyk MG, Chiou HC. Obstacles and advances in non-viral gene delivery. Curr Opin Mol Ther 2000; 2: 136-142.
2. Feigner PL, Barenholz Y, Behr JP, et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther 1997; 8: 511-512.
3. Zauner W, Ogris M, Wagner E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Adv Drug Del Rev 1998; 30: 97-113.
4. Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-1144.
5. Huang CH, Hung MC, Wagner E. Nonviral Vectors for Gene Therapy. Academic Press: San Diego, 1999.
6. Boussif O, Lezoualch F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297-7301.
7. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996; 3: 1074-1080.
8. Kircheis R, Kichler A, Wallner G, et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997; 4: 409-418.
9. Abdallah B, Hassan A, Benoist C, Goula D, Behr JP, Demeneix BA. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996; 7: 1947-1954.
10. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712-717.
11. Goula D, Benoist C, Mantero S, Merlo G, Levi G, Demeneix BA. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 1998; 5: 1291-1295.
12. Bragonzi A, Dina G, Villa A, et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000; 7: 1753-1760.
13. Poulain L, Ziller C, Muller CD, et al. Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives. Cancer Gene Ther 2000; 7: 644-652.
14. Ferrari S, Moro E, Pettenazzo A, Behr JP, Zacchello F, Scarpa M. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther 1997; 4: 1100-1106.
15. Goula D, Becker N, Lemkine GF, et al. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 2000; 7: 499-504.
16. Zou SM, Erbacher P, Remy JS, Behr JP. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2000; 2: 128-134.
17. Kircheis R, Schüller S, Brunner S, et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1999; 1: 111-120.
18. Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998; 5: 1425-1433.
19. Kircheis R, Wagner E. Polycation/DNA complexes for in vivo gene delivery. Gene Ther Reg 2000; 1: 95-114.
20. Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28-40.
21. Ogris M, Brunner S, Schüller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
22. Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643-650.
23. Erbacher P, Bettinger T, Belguise VP, et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1999; 1: 210-222.
24. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 1997; 4: 823-832.
25. Plank C, Zatloukal K, Cotten M, Mechtler K, Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug Chem 1992; 3: 533-539.
26. Wightman L, Patzelt E, Wagner E, Kircheis R. Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells. J Drug Target 1999; 7: 293-303.
27. Coll JL, Chollet P, Brambilla E, Desplanques D, Behr JP, Favrot M. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum Gene Ther 1999; 10: 1659-1666.
28. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A 1999; 96: 5177-5181.
29. Plank C, Mechtler K, Szoka FCJ, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.